Modern aspects of acne pathogenesis;Moderne aspekte der aknepathogenese

Aktuelle Dermatologie

Volumn 32, Issue 7, 2006, Pages 296-302

  Zouboulis, Christos C ^a  

^a DESSAU MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CHEMOKINE; CYTOKINE; LIGAND; LIPID; NEUROPEPTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ACNE VULGARIS; CIGARETTE SMOKING; COMEDO; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HAIR FOLLICLE; HUMAN; INFLAMMATION; PATHOGENESIS; PROPIONIBACTERIUM ACNES; REVIEW; SEBACEOUS GLAND; SKIN DISEASE;

EID: 33746616810     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-944576     Document Type: Review

References (74)

1. Zouboulis CC. Acne: Sebaceous gland action. Clin Dermatol 2004; 22: 360-366
2. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, Rosenfield R. What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-152
3. Zouboulis CC. Moderne Aknetherapie. Akt Dermatol 2003; 29: 49-57
4. Zouboulis CC. Acne: Current aspects on pathology and treatment. Dermatol Experiences 1999; 1: 6-37
5. Chiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 203; 139: 897-900
6. Zouboulis CC, Böhm M. Neuroendocrine regulation of sebocytes - a pathogenetic link between stress and acne. Exp Dermatol 2004; 13 (Suppl 4): 31-35
7. Green J, Sinclair RD. Perceptions of acne vulgaris in final year medical student written examination answers. Australas J Dermatol 2001; 42: 98-101
8. Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology 2003; 206: 24-28
9. Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Brit J Dermatol 1999; 141: 297-300
10. Walton S, Wyatt EH, Cunliffe WJ. Genetic control of sebum excretion and acne - a twin study. Brit J Dermatol 1988; 118: 393-396
11. Kirk KM, Evans DM, Farthing B, Martin NG. Genetic and environmental influences on acne in adolescent twins. Twin Res 2001; 4: 190
12. Bekaert C, Song M, Delvigne A. Acne neonatorum and familial hyper androgenism. Dermatology 1998; 196: 453-454
13. Ostlere LS, Rumsby G, Holownia P, Jacobs HS, Rustin MHA, Honour JW. Carrier status for steroid 21 -hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol 1998; 48: 209-215
14. Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002; 119: 1317-1322
15. Stewart ME, Grahek MO, Cambier LS, Wertz PW, Downing DT. Dilutional effect of increased sebaceous gland activity on the proportion of linoleic acid in sebaceous wax esters and in epidermal acylceramides. J Invest Dermatol 1986; 87: 733-736
16. Pochi PE, Strauss JS. Sebaceous gland response in man to the administration of testosterone, M-androstenedione, and dehydroisoandrosterone. J Invest Dermatol 1969; 52: 32-36
17. Chen W, Yang C-C, Sheu H-M, Seltmann H, Zouboulis CC. Expression of sex-determining genes in human sebaceous glands and their possible roles in pathogenesis of acne. J Eur Acad Dermatol Venereol; in Druck
18. Cunliffe W, Forster R. Androgen control of the pilosebaceous duct? Brit J Dermatol 1987; 116: 449
19. Thiboutot D, Knaggs H, Gilliland K, Lin G. Activity of 5-alpha-reductase and 17-beta-hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and without acne vulgaris. Dermatology 1998; 196: 38-42
20. Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J. Acne vulgaris in premenarchal girls. Arch Dermatol 1994; 130: 308-314
21. Stewart ME, Downing DT, Cook JS, Hansen JR, Strauss JS. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol 1992; 128: 1345-1348
22. Marynick SP, Chakmajian ZH, McCaffree DL, Herdon JH. Androgen excess in cystic acne. N Engl J Med 1983; 308: 981-986
23. Schmidt JB, Spona J, Huber J. Androgen receptor in hirsutism and acne. Gynecol Obstet Invest 1986; 22: 206-211
24. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995; 105: 209-214
25. Zouboulis CC. Therapie der Akne mit Antiandrogenen - Eine evidenzbasierte Übersicht. JDDG 2003; 1: 535-546
26. Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metabol 1993; 76: 524-528
27. Rosenfield RL, Deplewski D, Kentsis A, Ciletti N. Mechanisms of androgen induction of sebocyte differentiation. Dermatology 1998; 196: 43-46
28. Fimmel S, Saborowski A, Térouanne B, Sultan C, Zouboulis CC. Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes. Horm Metab Res; in Druck
29. Chen W, Yang C-C, Sheu H-M, Seltmann H, Zouboulis CC. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003; 121: 441-447
30. 2 are active in sebaceous glands. J Mol Med 2006; 84: 75-87
31. Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5α-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Brit J Dermatol; in Druck
32. Wrobel A, Seltmann H, Fimmel S, Müller-Decker K, Tsukada M, Bogdanoff B, Mandt N, Blume-Peytavi U, Orfanos CE, Zouboulis CC. Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol 2003; 120: 175-181
33. Zouboulis CC, Nestoris S, Adler YD, Picardo M, Camera E, Orth M, Orfanos CE, Cunliffe WJ. A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 2003; 139: 668-670
34. Zouboulis CC, Saborowski A, Boschnakow A. Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 2005; 210: 36-38
35. Trivedi NR, Cong Z, Nelson AM, Albert AJ, Rosamilia LL, Sivarajah S, Gilliland KL, Liu W, Mauger DT, Gabbay RA, Thiboutot DM. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol; in Druck
36. Norris JF, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Brit J Dermatol 1988; 118: 651-659
37. Cunliffe WJ, Holland DB, Clark SM, Stables GI. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Brit J Dermatol 2000; 142: 1084-1091
38. Jeremy AHT, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003; 121: 20-27
39. Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology 2001; 203: 277-279
40. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992; 98: 895-901
41. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, Ruhl R, Chen W, Nau H, Orfanos CE. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998; 196: 21-31
42. Antilla HS, Reitamo S, Saurat JH. Interleukin 1 immunoreactivity in sebaceous glands. Brit J Dermatol 1992; 127: 585-588
43. Boehm KD, Yun JK, Strohl KP, Elmets CA. Messenger RNAs for the multifunctional cytokines interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol 1995; 4: 335-341
44. Guy R, Green M, Kealey T. Modeling of acne in vitro. J Invest Dermatol 1996; 106: 176-182
45. Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M. Sebaceous glands in acne patients express high levels of neutral endopeptidase. Exp Dermatol 2002; 11: 241-247
46. Thielitz A, Reinhold D, Vetter R, Lendeckel U, Kähne T, Bank U, Helmuth M, Neubert K, Faust J, Hartig R, Wrenger S, Zouboulis CC, Ansorge S, Gollnick H. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) target major pathogenetic steps in acne initiation. J Invest Dermatol; in Druck
47. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR. Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 2002; 99: 7148-7153
48. Böhm M, Schiller M, Stander S, Seltmann H, Li Z, Brzoska T, Metze D, Schiöth HB, Skottner A, Seiffert K, Zouboulis CC, Luger TA. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002; 118: 533-539
49. Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC. Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res; in Druck
50. Alesci S, Bornstein SR. Neuroimmunoregulation of androgens in the adrenal gland and the skin. Horm Res 2000; 54: 281-286
51. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E, Zbytek B, Zipper J, Wortsman J, Paus R. Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?" Ann N YAcad Sci 1999; 885: 287-311
52. Zouboulis CC. The human skin as a hormone target and an endocrine gland. Hormones 2004; 3: 9-26
53. Letawe C, Boone M, Pierard GE. Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol 1998; 23: 56-58
54. 2 production in SZ95 human sebaceous gland cells. J Invest Dermatol 2006; 126: 42-48
55. Schaefer O. When the Eskimo comes to town. Nutr Today 1971; 6: 8-16
56. Steiner PE. Necropsies on Okinawans: anatomic and pathologic observations. Arch Pathol 1946; 42: 359-380
57. Simopoulos AP. Evolutionary aspects of diet and essential fatty acids. World Rev Nutr Diet 2001; 88: 18-27
58. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138: 1584-1590
59. Thiboutot DM, Strauss JS. Diet and acne revisited. Arch Dermatol 2002; 138: 1591-1592
60. Schäfer T, Nienhaus A, Vieluf D, Berger J, Ring J. Epidemiology of acne in the general population: the risk of smoking. Brit J Dermatol 2001; 145: 100-104
61. Firooz A, Sarhangnejad R, Davoudi SM, Nassiri-Kashani M. Acne and smoking: is there a relationship? BMC Dermatol 2005; 5: 2
62. Galobardes B, Davey Smith G, Jeffreys M, Kinra S, McCarron P. Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study. Am J Epidemiol 2005; 161: 1094-1101
63. Klaz I, Kochba I, Shohat T, Zarka S, Brenner S. Severe acne vulgaris and tobacco smoking in young men. J Invest Dermatol; in Druck
64. Tithof PK, Elgayyar M, Cho Y, Guan W, Fisher AB, Peters-Golden M. Polycyclic aromatic hydrocarbons present in cigarette smoke cause endothelial cell apoptosis by a phospholipase A2-dependent mechanism. FASEB J 2002; 16: 1463-1464
65. Zouboulis CC. Human skin: An independent peripheral endocrine organ. Horm Res 2000; 54: 230-242
66. Thompson RL, Pyke S, Scott EA, Thompson SG, Wood DA. Cigarette smoking, polyunsaturated fats, and coronary heart disease. Ann N Y Acad Sci 1993; 686: 130-138
67. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169: 1535-1541
68. Pivarcsi A, Bodai L, Rethi B, Kenderessy-Szabo A, Koreck A, Szell M, Beer Z, Bata-Csorgoo Z, Magocsi M, Rajnavolgyi E, Dobozy A, Kemeny L. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15: 721-730
69. Ingham E, Walters CE, Eady EA, Cove JH, Kearney JN, Cunliffe WJ. Inflammation in acne vulgaris: failure of skin micro-organisms to modulate keratinocyte interleukin 1 alpha production in vitro. Dermatology 1998; 196: 86-88
70. Nagy I, Pivarcsi A, Koreck A, Szell M, Urban E, Kemény L. Distinct strains of Propionibacterium acnes induces selective human β-defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors. J Invest Dermatol 2005; 124: 931-938
71. Oeff KM, Seltmann H, Hakiy NH, Bogdanoff B, Nastos A, Walters RJ, Fimmel S, Bornstein SR, Zouboulis CC. Differential modulation of Toll-like receptor 2 and 4 expression in human sebocytes. J Invest Dermatol 2002; 119: 319
72. Seltmann H, Zouboulis CC. Human sebocytes express CD14 molecules and their IL8 production is induced by both CD14-dependent and independent pathways. J Invest Dermatol 2001; 117: 804
73. Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, Hoebe K, Du X, Rutschmann S, Jiang Z, Bigby T, Nizet V, Zouboulis CC, Beutler B. A TLR2-responsive lipid effector pathway protects mammals against Gram-positive bacterial skin infections. Infect Immun 2005; 73: 4512-4521
74. Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, McDowell A, Seltmann H, Patrick S, Zouboulis CC, Kemény L. Propionibacterium acnes and LPS induce the expression of antibacterial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect; in Druck